Andrew T Hattersley Selected Research

Blood Glucose (Blood Sugar)

10/2022	Patient-led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweight.
11/2018	Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes.
3/2016	Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight.
11/2008	Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene.
6/2005	Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew T Hattersley Research Topics

Disease

102	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2002
35	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2003
29	Insulin Resistance 12/2021 - 01/2002
26	Hyperglycemia 09/2023 - 12/2002
25	Birth Weight (Birth Weights) 04/2024 - 01/2004
17	Mason-Type Diabetes 01/2021 - 01/2002
14	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2003
11	Diabetes Mellitus 01/2023 - 12/2002
11	Obesity 01/2021 - 04/2008
10	Genetic Risk Score 01/2023 - 10/2013
9	Permanent Neonatal Diabetes Mellitus 01/2019 - 12/2004
6	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2024 - 10/2010
6	Hyperinsulinism (Hyperinsulinemia) 01/2022 - 05/2004
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020 - 09/2007
4	Cysts 02/2015 - 10/2001
3	Deafness (Deaf Mutism) 11/2023 - 04/2008
3	Lipodystrophy 01/2022 - 01/2004
3	Anemia 01/2021 - 10/2020
3	Kidney Diseases (Kidney Disease) 02/2015 - 12/2002
3	Hypothyroidism 12/2013 - 11/2009
3	Familial Partial Lipodystrophy (Dunnigan Syndrome) 03/2007 - 07/2003
3	Type 3 Maturity-Onset Diabetes of the Young 12/2003 - 11/2002
2	Pre-Eclampsia (Preeclampsia) 01/2024 - 10/2023
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2024 - 10/2023
2	Premature Birth (Birth, Premature) 10/2023 - 06/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 12/2021
2	Congenital Hyperinsulinism 11/2022 - 01/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2005
2	Chronic Renal Insufficiency 01/2022 - 12/2013
2	Latent Autoimmune Diabetes in Adults 01/2021 - 06/2006
2	Disease Progression 01/2021 - 01/2018
2	Edema (Dropsy) 01/2020 - 01/2018
2	Dyslipidemias (Dyslipidemia) 01/2020 - 05/2004
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 01/2018
2	Overweight 12/2018 - 01/2009
2	Weight Gain 08/2018 - 01/2018
2	Exocrine Pancreatic Insufficiency 01/2016 - 03/2013
2	Microcephaly 11/2015 - 10/2013
2	Solitary Kidney 02/2015 - 04/2002

Drug/Important Bio-Agent (IBA)

76	Insulin (Novolin)FDA Link 01/2023 - 01/2002
51	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2002
21	GlucokinaseIBA 11/2023 - 09/2003
21	C-PeptideIBA 01/2023 - 11/2008
18	AutoantibodiesIBA 01/2023 - 09/2007
16	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2002
12	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 02/2011 - 01/2002
11	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 10/2003
11	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2003
11	Transcription Factors (Transcription Factor)IBA 12/2015 - 01/2002
11	Hepatocyte Nuclear Factor 1-betaIBA 07/2009 - 10/2001
9	Hepatocyte Nuclear FactorsIBA 01/2020 - 05/2003
9	Triglycerides (Triacylglycerol)IBA 01/2018 - 12/2005
8	LipidsIBA 12/2022 - 01/2002
8	P-2 (P 2)IBA 01/2020 - 06/2007
8	Adenosine Triphosphate (ATP)IBA 08/2012 - 11/2004
7	CreatinineIBA 12/2022 - 02/2011
6	KATP ChannelsIBA 01/2019 - 02/2003
5	Blood Glucose (Blood Sugar)IBA 10/2022 - 06/2005
5	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 01/2002
4	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024 - 09/2015
4	AntibodiesIBA 11/2023 - 07/2012
4	Glyburide (Glibenclamide)FDA LinkGeneric 01/2021 - 03/2005
4	ThiazolidinedionesIBA 10/2020 - 10/2003
4	ProinsulinIBA 01/2020 - 07/2005
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2024 - 01/2018
3	AntigensIBA 01/2023 - 01/2019
3	EnzymesIBA 01/2021 - 06/2005
3	Hemoglobins (Hemoglobin)IBA 10/2020 - 11/2008
3	AdiponectinIBA 03/2016 - 01/2012
3	HDL CholesterolIBA 03/2016 - 12/2005
3	C-Reactive ProteinIBA 07/2012 - 12/2005
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 10/2023 - 01/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2023 - 01/2021
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2023 - 01/2023
2	CanagliflozinIBA 01/2023 - 01/2023
2	Pioglitazone (Actos)FDA Link 01/2023 - 01/2023
2	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2022 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 11/2018
2	Uric Acid (Urate)IBA 01/2022 - 05/2003
2	LeptinIBA 01/2022 - 10/2003
2	Glucagon (Glukagon)FDA Link 01/2021 - 11/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020 - 01/2014
2	Zinc Transporter 8IBA 01/2020 - 01/2019
2	Vitamin D FDA LinkGeneric 01/2019 - 03/2016
2	IncretinsIBA 01/2019 - 01/2018
2	Hormones (Hormone)IBA 11/2018 - 01/2012
2	Dihydrotachysterol (AT 10)IBA 01/2018 - 01/2009
2	Gonadal Steroid Hormones (Sex Hormones)IBA 10/2016 - 02/2010
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2016 - 12/2013
2	Glutamic Acid (Glutamate)FDA Link 02/2015 - 06/2011
2	Iodide Peroxidase (Deiodinase)IBA 02/2014 - 12/2013
2	cyclo(Arg-Pro) (CI 4)IBA 01/2014 - 12/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2012 - 08/2009
2	Thiamine (Aneurin)FDA Link 09/2012 - 06/2012
2	Lipoproteins (Lipoprotein)IBA 05/2012 - 01/2002

Therapy/Procedure

32	Therapeutics 02/2024 - 03/2005
8	Precision Medicine 02/2024 - 01/2017
6	Glycemic Control 04/2023 - 11/2003
3	Injections 01/2012 - 02/2008
2	Enzyme Replacement Therapy 08/2018 - 03/2013